Loading…
Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice
The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental Cryptosporidium parvum ( C. parvum ) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz...
Saved in:
Published in: | Journal of parasitic diseases 2024-12, Vol.48 (4), p.849-859 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c204y-fcea6e28d971daf19eafb0c4b2ea95f4232da5a61aac6c57dd1b4a647ac29b4d3 |
container_end_page | 859 |
container_issue | 4 |
container_start_page | 849 |
container_title | Journal of parasitic diseases |
container_volume | 48 |
creator | Mahmoud, Nada R. Younis, Azza I. Zalat, Rabab S. Soliman, Ahmed S. A. Khater, Mona M. |
description | The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental
Cryptosporidium parvum
(
C. parvum
) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz Research Institute. Starting from the 7th day post infection (p.i), therapeutics were given to immunosuppressed infected mice, which were divided as follows; oral NTZ treated group (0.2 mg/g/day for 6 consecutive days), six-PRP-treated groups (0.5 μl/g/week) to be administered intravenously (IV) in 1st, 2nd, 3rd week as PRP alone in (3 groups) and combined with oral NTZ (0.2 mg/g/day for 6 consecutive days) in (3 groups). Parasitological, histopathological and immunohistochemical assessments of therapeutics under study were done. Fecal pellets collected from groups at different intervals were stained using modified Ziehl–Neelsen and examined under microscope. Among PRP-treated groups, the highest significant percentage of oocyst reduction (89.96%) was observed in the group received 3 doses of PRP in combination with NTZ on the 35th day post infection. Likewise, the histopathological examination of small intestinal tissue sections showed improvement in villous architecture with mild to moderate stunting and moderate inflammatory infiltrates in lamina propria. Immunohistochemical staining of small intestinal tissue sections showed moderate increase in the expression of TGF-β1. Therefore, PRP can be a novel strategy in the treatment of cryptosporidiosis particularly when combined with NTZ. |
doi_str_mv | 10.1007/s12639-024-01713-y |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3154174406</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3154174406</sourcerecordid><originalsourceid>FETCH-LOGICAL-c204y-fcea6e28d971daf19eafb0c4b2ea95f4232da5a61aac6c57dd1b4a647ac29b4d3</originalsourceid><addsrcrecordid>eNqNkc9u1DAQxiMEoqXwAhyQJS5cAv6XOOGGVkCRKnEpZ2tiT1pXSWxsZ0WeoS-Nd7eAxAFxmhnPbz5r5quql4y-ZZSqd4nxVvQ15bKmTDFRb4-qc9qrpqaKisfHnNWK9e1Z9SylO0qb8t49rc5EL3shW3Ve3V_fYoSAa3aGBJ9xyQ4m4kcSJsg4YSbRmdtDlWYgcANuSZngj4DRzYUu8C5uIfsUfHTWrTMJEPcluGVEk51f3peU7N3ek5RXux0qN8_r4tMaQsSU0JLZGXxePRlhSvjiIV5U3z59vN5d1ldfP3_ZfbiqDadyq0eD0CLvbNnOwsh6hHGgRg4coW9GyQW30EDLAExrGmUtGyS0UoHh_SCtuKjenHRD9N9XTFnPLhmcJljQr0kL1kimpKTtf6BcdLQTqi_o67_QO7_GpSxypKjsOn6g-Iky0acUcdSh3BHiphnVB1f1yVVdXNVHV_VWhl49SK_DjPb3yC8bCyBOQCqt5Qbjn7__IfsThnKyWg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3123048829</pqid></control><display><type>article</type><title>Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice</title><source>Springer Nature</source><creator>Mahmoud, Nada R. ; Younis, Azza I. ; Zalat, Rabab S. ; Soliman, Ahmed S. A. ; Khater, Mona M.</creator><creatorcontrib>Mahmoud, Nada R. ; Younis, Azza I. ; Zalat, Rabab S. ; Soliman, Ahmed S. A. ; Khater, Mona M.</creatorcontrib><description>The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental
Cryptosporidium parvum
(
C. parvum
) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz Research Institute. Starting from the 7th day post infection (p.i), therapeutics were given to immunosuppressed infected mice, which were divided as follows; oral NTZ treated group (0.2 mg/g/day for 6 consecutive days), six-PRP-treated groups (0.5 μl/g/week) to be administered intravenously (IV) in 1st, 2nd, 3rd week as PRP alone in (3 groups) and combined with oral NTZ (0.2 mg/g/day for 6 consecutive days) in (3 groups). Parasitological, histopathological and immunohistochemical assessments of therapeutics under study were done. Fecal pellets collected from groups at different intervals were stained using modified Ziehl–Neelsen and examined under microscope. Among PRP-treated groups, the highest significant percentage of oocyst reduction (89.96%) was observed in the group received 3 doses of PRP in combination with NTZ on the 35th day post infection. Likewise, the histopathological examination of small intestinal tissue sections showed improvement in villous architecture with mild to moderate stunting and moderate inflammatory infiltrates in lamina propria. Immunohistochemical staining of small intestinal tissue sections showed moderate increase in the expression of TGF-β1. Therefore, PRP can be a novel strategy in the treatment of cryptosporidiosis particularly when combined with NTZ.</description><identifier>ISSN: 0971-7196</identifier><identifier>EISSN: 0975-0703</identifier><identifier>DOI: 10.1007/s12639-024-01713-y</identifier><identifier>PMID: 39493467</identifier><language>eng</language><publisher>New Delhi: Springer India</publisher><subject>albino ; Cryptosporidiosis ; Cryptosporidium parvum ; Health Promotion and Disease Prevention ; histopathology ; immunohistochemistry ; Infections ; Infectious Diseases ; intestines ; intravenous injection ; Lamina propria ; males ; Medicine ; Medicine & Public Health ; oocysts ; Original Article ; Platelets ; research institutions ; Small intestine ; Transforming growth factor-b1</subject><ispartof>Journal of parasitic diseases, 2024-12, Vol.48 (4), p.849-859</ispartof><rights>Indian Society for Parasitology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c204y-fcea6e28d971daf19eafb0c4b2ea95f4232da5a61aac6c57dd1b4a647ac29b4d3</cites><orcidid>0000-0001-8499-5858</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39493467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mahmoud, Nada R.</creatorcontrib><creatorcontrib>Younis, Azza I.</creatorcontrib><creatorcontrib>Zalat, Rabab S.</creatorcontrib><creatorcontrib>Soliman, Ahmed S. A.</creatorcontrib><creatorcontrib>Khater, Mona M.</creatorcontrib><title>Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice</title><title>Journal of parasitic diseases</title><addtitle>J Parasit Dis</addtitle><addtitle>J Parasit Dis</addtitle><description>The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental
Cryptosporidium parvum
(
C. parvum
) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz Research Institute. Starting from the 7th day post infection (p.i), therapeutics were given to immunosuppressed infected mice, which were divided as follows; oral NTZ treated group (0.2 mg/g/day for 6 consecutive days), six-PRP-treated groups (0.5 μl/g/week) to be administered intravenously (IV) in 1st, 2nd, 3rd week as PRP alone in (3 groups) and combined with oral NTZ (0.2 mg/g/day for 6 consecutive days) in (3 groups). Parasitological, histopathological and immunohistochemical assessments of therapeutics under study were done. Fecal pellets collected from groups at different intervals were stained using modified Ziehl–Neelsen and examined under microscope. Among PRP-treated groups, the highest significant percentage of oocyst reduction (89.96%) was observed in the group received 3 doses of PRP in combination with NTZ on the 35th day post infection. Likewise, the histopathological examination of small intestinal tissue sections showed improvement in villous architecture with mild to moderate stunting and moderate inflammatory infiltrates in lamina propria. Immunohistochemical staining of small intestinal tissue sections showed moderate increase in the expression of TGF-β1. Therefore, PRP can be a novel strategy in the treatment of cryptosporidiosis particularly when combined with NTZ.</description><subject>albino</subject><subject>Cryptosporidiosis</subject><subject>Cryptosporidium parvum</subject><subject>Health Promotion and Disease Prevention</subject><subject>histopathology</subject><subject>immunohistochemistry</subject><subject>Infections</subject><subject>Infectious Diseases</subject><subject>intestines</subject><subject>intravenous injection</subject><subject>Lamina propria</subject><subject>males</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>oocysts</subject><subject>Original Article</subject><subject>Platelets</subject><subject>research institutions</subject><subject>Small intestine</subject><subject>Transforming growth factor-b1</subject><issn>0971-7196</issn><issn>0975-0703</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqNkc9u1DAQxiMEoqXwAhyQJS5cAv6XOOGGVkCRKnEpZ2tiT1pXSWxsZ0WeoS-Nd7eAxAFxmhnPbz5r5quql4y-ZZSqd4nxVvQ15bKmTDFRb4-qc9qrpqaKisfHnNWK9e1Z9SylO0qb8t49rc5EL3shW3Ve3V_fYoSAa3aGBJ9xyQ4m4kcSJsg4YSbRmdtDlWYgcANuSZngj4DRzYUu8C5uIfsUfHTWrTMJEPcluGVEk51f3peU7N3ek5RXux0qN8_r4tMaQsSU0JLZGXxePRlhSvjiIV5U3z59vN5d1ldfP3_ZfbiqDadyq0eD0CLvbNnOwsh6hHGgRg4coW9GyQW30EDLAExrGmUtGyS0UoHh_SCtuKjenHRD9N9XTFnPLhmcJljQr0kL1kimpKTtf6BcdLQTqi_o67_QO7_GpSxypKjsOn6g-Iky0acUcdSh3BHiphnVB1f1yVVdXNVHV_VWhl49SK_DjPb3yC8bCyBOQCqt5Qbjn7__IfsThnKyWg</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Mahmoud, Nada R.</creator><creator>Younis, Azza I.</creator><creator>Zalat, Rabab S.</creator><creator>Soliman, Ahmed S. A.</creator><creator>Khater, Mona M.</creator><general>Springer India</general><general>Springer Nature B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7S9</scope><scope>L.6</scope><orcidid>https://orcid.org/0000-0001-8499-5858</orcidid></search><sort><creationdate>202412</creationdate><title>Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice</title><author>Mahmoud, Nada R. ; Younis, Azza I. ; Zalat, Rabab S. ; Soliman, Ahmed S. A. ; Khater, Mona M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c204y-fcea6e28d971daf19eafb0c4b2ea95f4232da5a61aac6c57dd1b4a647ac29b4d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>albino</topic><topic>Cryptosporidiosis</topic><topic>Cryptosporidium parvum</topic><topic>Health Promotion and Disease Prevention</topic><topic>histopathology</topic><topic>immunohistochemistry</topic><topic>Infections</topic><topic>Infectious Diseases</topic><topic>intestines</topic><topic>intravenous injection</topic><topic>Lamina propria</topic><topic>males</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>oocysts</topic><topic>Original Article</topic><topic>Platelets</topic><topic>research institutions</topic><topic>Small intestine</topic><topic>Transforming growth factor-b1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mahmoud, Nada R.</creatorcontrib><creatorcontrib>Younis, Azza I.</creatorcontrib><creatorcontrib>Zalat, Rabab S.</creatorcontrib><creatorcontrib>Soliman, Ahmed S. A.</creatorcontrib><creatorcontrib>Khater, Mona M.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>AGRICOLA</collection><collection>AGRICOLA - Academic</collection><jtitle>Journal of parasitic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mahmoud, Nada R.</au><au>Younis, Azza I.</au><au>Zalat, Rabab S.</au><au>Soliman, Ahmed S. A.</au><au>Khater, Mona M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice</atitle><jtitle>Journal of parasitic diseases</jtitle><stitle>J Parasit Dis</stitle><addtitle>J Parasit Dis</addtitle><date>2024-12</date><risdate>2024</risdate><volume>48</volume><issue>4</issue><spage>849</spage><epage>859</epage><pages>849-859</pages><issn>0971-7196</issn><eissn>0975-0703</eissn><abstract>The present study was designed to assess the possible effects of platelet rich plasma (PRP) when used individually and in combination with nitazoxanide (NTZ) on experimental
Cryptosporidium parvum
(
C. parvum
) infection. It was conducted on 100 male albino mice, laboratory bred in Theodore Bilharz Research Institute. Starting from the 7th day post infection (p.i), therapeutics were given to immunosuppressed infected mice, which were divided as follows; oral NTZ treated group (0.2 mg/g/day for 6 consecutive days), six-PRP-treated groups (0.5 μl/g/week) to be administered intravenously (IV) in 1st, 2nd, 3rd week as PRP alone in (3 groups) and combined with oral NTZ (0.2 mg/g/day for 6 consecutive days) in (3 groups). Parasitological, histopathological and immunohistochemical assessments of therapeutics under study were done. Fecal pellets collected from groups at different intervals were stained using modified Ziehl–Neelsen and examined under microscope. Among PRP-treated groups, the highest significant percentage of oocyst reduction (89.96%) was observed in the group received 3 doses of PRP in combination with NTZ on the 35th day post infection. Likewise, the histopathological examination of small intestinal tissue sections showed improvement in villous architecture with mild to moderate stunting and moderate inflammatory infiltrates in lamina propria. Immunohistochemical staining of small intestinal tissue sections showed moderate increase in the expression of TGF-β1. Therefore, PRP can be a novel strategy in the treatment of cryptosporidiosis particularly when combined with NTZ.</abstract><cop>New Delhi</cop><pub>Springer India</pub><pmid>39493467</pmid><doi>10.1007/s12639-024-01713-y</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-8499-5858</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0971-7196 |
ispartof | Journal of parasitic diseases, 2024-12, Vol.48 (4), p.849-859 |
issn | 0971-7196 0975-0703 |
language | eng |
recordid | cdi_proquest_miscellaneous_3154174406 |
source | Springer Nature |
subjects | albino Cryptosporidiosis Cryptosporidium parvum Health Promotion and Disease Prevention histopathology immunohistochemistry Infections Infectious Diseases intestines intravenous injection Lamina propria males Medicine Medicine & Public Health oocysts Original Article Platelets research institutions Small intestine Transforming growth factor-b1 |
title | Therapeutic potential of platelet rich plasma against experimental Cryptosporidium parvum infection: in vivo study in immunosuppressed mice |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T23%3A23%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20potential%20of%20platelet%20rich%20plasma%20against%20experimental%20Cryptosporidium%20parvum%20infection:%20in%20vivo%20study%20in%20immunosuppressed%20mice&rft.jtitle=Journal%20of%20parasitic%20diseases&rft.au=Mahmoud,%20Nada%20R.&rft.date=2024-12&rft.volume=48&rft.issue=4&rft.spage=849&rft.epage=859&rft.pages=849-859&rft.issn=0971-7196&rft.eissn=0975-0703&rft_id=info:doi/10.1007/s12639-024-01713-y&rft_dat=%3Cproquest_cross%3E3154174406%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c204y-fcea6e28d971daf19eafb0c4b2ea95f4232da5a61aac6c57dd1b4a647ac29b4d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3123048829&rft_id=info:pmid/39493467&rfr_iscdi=true |